You are here: Home » News-CM » Equities » Market Report
Business Standard

Sensex climbs 680 pts, Nifty tops 12,600 as banks shine

Capital Market 

The equity benchmarks ended at record high levels on Tuesday, led by banks and financial stocks. The Nifty managed to closed above 12,600 mark. Sentiment was upbeat after US drug maker Pfizer said large-scale trials of its coronavirus vaccine showed it was more than 90% effective in preventing infection.

As per provisional closing data, the barometer index, the S&P BSE Sensex, rallied 680.22 points or 1.6% at 43,277.65. The Nifty 50 index spurted 177.10 points or 1.42% at 12,638.15. Both these indices extended gains for the seventh trading session.

The Sensex hit a record high of 43,316.44 while the Nifty hit a record high of 12,643.90 in late trade.

The broader market, however, declined. The S&P BSE Mid-Cap index fell 0.1% while the S&P BSE Small-Cap index declined 0.48%.

Sellers outpaced buyers. On the BSE, 1,243 shares rose and 1,467 shares fell. A total of 181 shares were unchanged.

COVID-19 Update:

Total COVID-19 confirmed cases worldwide stood at 5,09,13,451 with 12,63,089 deaths. India reported 5,01,214 active cases of COVID-19 infection and 1,27,059 deaths while 79,63,457 patients have been discharged, according to the data from the Ministry of Health and Family Welfare, Government of India.

Bihar Elections:

The National Democratic Alliance is surging ahead of the Mahagathbandhan in Bihar polls on Tuesday as the counting of votes for the 243 assembly seats is underway. After initial trends showed a close neck-and-neck contest between the two rival alliances, the incumbent Nitish Kumar-led Janata Dal United (JDU) and Bharatiya Janata Party (BJP) alliance seem to be leading in 130 seats, well above the halfway mark of 122.

Buzzing Segment:

Shares of airline companies were trading higher as progress with Covid-19 vaccine lifted investors' sentiment.

InterGlobe Aviation jumped 8.53% to Rs 1618.95 while SpiceJet traded 2.4% higher at Rs 51.20 on BSE.

Investors hoped that a vaccine may revive the travel and tourism business across the world.

Earnings Impact:

GAIL (India) jumped 4.91%. The state-owned natural gas processing and distribution company's consolidated net profit slipped 8.51% to Rs 1,068.16 crore on 24.32% drop in revenue from operations to Rs 13,809.86 crore in Q2 September 2020 over Q2 September 2019. Profit before tax (PBT) skid 16.08% to Rs 1,432 crore in Q2 September 2020 as against Rs 1,706.47 crore in Q2 September 2019. Total tax expense for the quarter declined 32.48% to Rs 363.84 crore as against Rs 538.89 crore in Q2 September 2019.

Hindalco Industries fell 1.93% to Rs 190.85 after the company's consolidated net profit tumbled 60.3% to Rs 387 crore on 5.3% rise in revenue from operations to Rs 31,237 crore in Q2 FY21 over Q2 FY20. The company said that there was a one-time impact of Rs 1,398 crore on account of the divestiture of the Lewisport unit of Aleris. EBITDA jumped 31.9% to Rs 5,171 crore in Q2 September 2020 from Rs 3,918 crore in Q2 September 2019.

Motherson Sumi jumped 4.07%. The auto component maker's consolidated net profit fell 12.2% to Rs 337.58 crore on 1.98% decline in total revenues from operations to Rs 14,957.21 crore in Q2 FY21 over Q2 FY20. Profit before tax in Q2 September 2020 stood at Rs 553.58 crore, up by 0.8% from Rs 549.31 crore in Q2 September 2019. Total tax expense during the quarter declined by 3.5% year-on-year (YoY) to Rs 165.65 crore. With improved operating performance and debt repayments, net debt reduced from Rs 9,083 crore to Rs 7,512 crore between 30 June 2020 to 30 September 2020. Further liquidity also enhanced from Rs 10,037 crore to Rs 11,629 crore between 30 June 2020 to 30 September 2020.

The company said that new orders worth Rs 14,694 crore (euro 1.7 billion) were received while orders worth Rs 19,016 crore (euro 2.2 billion) were executed during H1 FY20-21. Total order book, at SMRP BV level, was Rs 113,234 crore (euro 13.1 billion) for H1 FY20-21.

Mahindra & Mahindra (M&M) rose 0.55% after the company reported 88% decline in net profit to Rs 162 crore in Q2 FY21 from Rs 1355 crore in Q2 FY20. M&M's profit before tax in Q2 September 2020 stood at Rs 587 crore, down by 67% from Rs 1758 crore in Q2 September 2019. Revenues rose by 6% year-on-year (YoY) to Rs 11,590 crore during the quarter. The company incurred an exceptional expenditure of Rs 1,149.46 crore in Q2 September 2020 towards impairment provision for certain long-term investments. While total vehicle sales declined by 21% to 87,332 units, tractor sales jumped by 31% to 89,597 units in Q2 FY21 over Q2 FY20. Total exports (vehicles and tractors) during the September quarter tumbled 33% YoY to 7,103 units.

E. I. D. Parry (India) rose 0.51% after the sugar maker posted a 48% rise in consolidated net profit to Rs 562.70 crore in Q2 September 2020 from Rs 380.36 crore in Q2 September 2019. Consolidated net sales grew by 2.8% to Rs 5836.21 crore in Q2 September 2020 from Rs 5675 crore in Q2 September 2019. Consolidated EBITDA for Q2 September 2020 came at Rs 890 crore, registering a 31% rise year on year from Rs 681 crore in the corresponding period last year.

JK Cement fell 1.14%. The cement maker's consolidated net profit jumped 170% to Rs 221.56 crore in Q2 September 2020 from Rs 81.9 crore in Q2 September 2019. Consolidated revenue from operations stood at Rs 1634.4 crore in Q2 September 2020, rising 24% year on year from Rs 1317.63 crore in Q2 September 2019.

Stock in Spotlight:

Pfizer rose 2.66% after the company's US-based parent said that its vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study. Pfizer Inc. and BioNTech SE announced their mRNA-based vaccine candidate against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on 8 November 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study.

Global Markets:

The US Dow Jones Futures were up 193.5 points, indicating a positive start in Wall Street today.

European shares rose across the board while most Asian stocks advanced on Tuesday as investors in the region reacted to positive developments overnight on the coronavirus vaccine front.

China's Shanghai Composite fell 0.4%. Authorities in China's financial hub of Shanghai have quarantined 186 people and conducted coronavirus tests on more than 8,000 after a freight handler at the city's main international airport tested positive for the virus.

Meanwhile, China's consumer price index rose 0.5% in October from a year ago, according to data from the country's National Bureau of Statistics. The producer price index for China declined 2.1% year-on-year in October, unchanged from a 2.1% drop in September.

In US, the Dow Jones Industrial Average and S&P 500 jumped on Monday as investors cheered trial data from drugmakers Pfizer and BioNTech indicating their Covid-19 vaccine is more than 90% effective. However, the Nasdaq Composite closed lower as traders rotated out of high-flying technology names that outperformed during the pandemic into more beaten-down value stocks.

While the vaccine study is still ongoing and requires approval, Pfizer and BioNTech said they had found no serious safety concerns so far and expected to seek U. S. emergency use authorization later this month.

The 90% effective rate from Pfizer and Germany's BioNTech was better than what the market was expecting. Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, has said that a vaccine that was 50% to 60% effective would be acceptable.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, November 10 2020. 15:30 IST